Upcoming events

Prescribing Information links and Adverse Event reporting statement can be found at the bottom of this page.

This webinar is intended for UK healthcare professionals and other relevant decision makers only

Lungs image

Respiratory

When

4 lunchtime sessions taking place every Thursday for 4 weeks, commencing 5tth June 2025

Start time

12:30 - 14:00

Where

SpotMe webinar platform

Speakers

Meg Allwood, Refine Respiratory Ltd & Frances Barrett, Barrett McGrath EMS

Click here for Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) Prescribing Information

Click here for Anoro Ellipta (umeclidinium/vilanterol) Prescribing Information

Click here for Incruse Ellipta (umeclidinium) Prescribing Information

Click here for Relvar Ellipta (fluticasone furoate/vilanterol) 92/22 μg Prescribing Information

Click here for Ventolin Accuhaler (salbutamol sulfate) Prescribing Information

Click here for Ventolin Evohaler (salbutamol sulfate) Prescribing Information

Click here for Seretide Accuhaler (fluticasone propionate/salmeterol xinafoate) 500/50 μg Prescribing Information

PM-GB-RS-WCNT-250007 | April 2025

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GSK on 0800 221 441 or UKSafety@gsk.com.

PM-GB-NA-WCNT-200004 | July 2024

Welcome to GSKpro UK

For UK healthcare professionals - information on GSK's medicines and vaccines, educational resources and more.

I’m a UK healthcare professional

Important notice: this site is intended for UK healthcare professionals. By entering this site, you are confirming that you are a UK healthcare professional. This site contains promotional information.

I’m a member of the UK public

This site is intended for members of the UK public, patients and their carers.

   February 2025 | PM-GB-NA-WCNT-200006 (V8.0)

Open cookie banner
Hide cookie banner